28 completed, 11 unknown, 7 terminated, 2 withdrawn. 18 Phase 4, 14 Phase 3, 10 Not applicable, 9 Phase 2, 1 Phase 1.
Follow Milnacipran: new trials by email Literature Review of Milnacipran trials Research Report on Milnacipran
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Foot Massage Performed to the Mother After Bırth on Breastfeedıng Success, Sleep Qualıty and Newborn Stress Educational with milnacipran, Locally Directed Therapy - Postpartum Women | Not applicable | Active not recruiting | Melek Nur KEÇELİ | 70 | 2025-01-01 | 2025-01-22 |
| Efficacy of Hydroxyzine for Patients With Panic Disorder Hydroxyzine, Escitalopram Oxalate - Panic Disorder | Phase 4 | Not yet recruiting | Sultan Qaboos University | 80 | 2023-12-30 | 2023-02-21 |
| Effect of Milnacipran / Gabapentin in Fibromyalgia Milnacipran, Gabapentin, Combined gabapentin/milnacipran - Fibromyalgia | Not applicable | Unknown | Mansoura University | 75 | 2022-06-01 | 2022-05-20 |
| Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Ketamine, Milnacipran, Placebo - Depression | Phase 2 / Phase 3 | Completed | University Hospital, Lille | 42 | 2016-09-08 | 2025-12-16 |
| Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome Milnacipran and D-cycloserine - Post Treatment Lyme Syndrome (PTLS), Chronic Pain | Not applicable | Terminated | New York State Psychiatric Institute | 4 | 2016-01-16 | 2020-06-01 |
| Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica Morphine, Milnacipran - Neuropathic Pain | Phase 2 | Unknown | Rambam Health Care Campus | 150 | 2013-07-01 | 2019-04-02 |
| Prospective Study of the Influence of the Diffuse Noxious Inhibitory Controls of the Pain on the Efficacy of Milnacipran in Fibromyalgia Therapy Milnacipran, Placebo - Fibromylagia | Phase 2 | Unknown | University Hospital, Clermont-Ferrand | 48 | 2013-04-01 | 2014-07-08 |
| Milnacipran (Savella) in Irritable Bowel Syndrome (IBS) Milnacipran, Placebo - Irritable Bowel Syndrome | Phase 2 | Terminated | Spencer Dorn, MD, MPH | 2 | 2012-04-01 | 2017-04-13 |
| Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder Aripiprazole, switching to different class of antidepressant - Major Depressive Disorder | Not applicable | Unknown | Korea University | 90 | 2011-11-01 | 2011-12-08 |
| The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients Milnacipran - Systemic Lupus Erythematosus, Widespread Pain | Phase 4 | Withdrawn | Loma Linda University | 2011-10-01 | 2015-09-18 | |
| Study to Evaluate the Efficacy of Milnacipran in the Treatment of Pain Due to Osteoarthritis Milnacipran, Placebo - Osteoarthritis | Phase 4 | Unknown | Analgesic Solutions | 50 | 2011-07-01 | 2011-08-17 |
| Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia : A 13-week Randomized, Placebo Controlled Cross Over Trial Milnacipran, Placebo - Fibromyalgia, Neurocognition | Phase 3 | Completed | Duke University | 26 | 2011-07-01 | 2023-10-26 |
| Study Evaluated the Effectiveness of Milnacipran to Reduce Pain Levels in Individuals With Chronic Migraine Milnacipran, Placebo - Chronic Migraine | Not applicable | Completed | Timothy Smith | 37 | 2011-06-01 | 2022-08-12 |
| Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia Milnacipran, Placebo - Primary Fibromyalgia | Phase 2 | Terminated | Forest Laboratories | 116 | 2011-04-30 | 2019-05-14 |
| A Placebo Controlled, Randomized, Double Blind Trial of Milnacipran for the Treatment of Idiopathic Neuropathy Pain Milnacipran, Placebo - Idiopathic Peripheral Neuropathy | Phase 3 | Terminated | Columbia University | 6 | 2011-04-05 | 2020-09-03 |
| Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia Milnacipran - Primary Fibromyalgia | Phase 2 | Terminated | Forest Laboratories | 57 | 2011-04-01 | 2013-09-30 |
| Preventive Treatment of Episodic and Chronic Migraine milnacipran - Migraine With Aura, Migraine Without Aura | Phase 4 | Unknown | California Medical Clinic for Headache | 45 | 2011-04-01 | 2011-03-22 |
| Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia in an Elderly Population Savella - Fibromyalgia | Phase 3 | Terminated | Banner Health | 20 | 2011-03-01 | 2011-08-17 |
| Effect of Milnacipran on Pain in Fibromyalgia Milnacipram - Fibromyalgia | Phase 4 | Completed | University of California, San Diego | 8 | 2011-02-01 | 2019-09-24 |
| Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism Milnacipran, Placebo - Autism Spectrum Disorder, Asperger Syndrome | Phase 4 | Completed | Montefiore Medical Center | 10 | 2011-02-01 | 2020-02-27 |
Showing 20 of 50. Sign in to see all of them.
Fibromyalgia (23) · Pain (10) · Depression (8) · Fatigue (5) · Arthritis, Rheumatoid (2) · Chronic Pain (2) · Drug-Related Side Effects and Adverse Reactions (2) · Neuralgia (2) · Osteoarthritis (2) · Abdominal Pain (1) · Asperger Syndrome (1) · Autism Spectrum Disorder (1) · Autistic Disorder (1) · Back Pain (1) · Coitus (1)
Forest Laboratories (8) · Samsung Medical Center (4) · Duke University (3) · Pierre Fabre Medicament (3) · Brigham and Women's Hospital (2) · Albany Medical College (1) · Analgesic Solutions (1) · Banner Health (1) · Beth Israel Medical Center (1) · California Medical Clinic for Headache (1) · Chang Gung Memorial Hospital (1) · Columbia University (1) · Dr. Norman Harden (1) · Indiana University (1) · Korea University (1)
United States (32) · South Korea (5) · France (4) · Czechia (2) · Finland (2) · Germany (2) · Italy (2) · Norway (2) · Portugal (2) · Romania (2) · Spain (2) · Sweden (2) · Taiwan (2) · Denmark (1) · Egypt (1)
Allan Spera (3) · Doh Kwan Kim, M.D., Ph.D. (3) · Patricia M D'Astoli, LPN (2) · Amr M Yassin, MD (1) · Ashwin A Patkar, MD (1) · Benjamin H Natelson, MD (1) · Candace S Brown, PharmD (1) · Changsu Han, MD,PhD, MHS (1) · Charles E. Argoff, MD (1) · Daniel Clauw, MD (1) · Davi M Marks, MD (1) · David B Kudrow, MD (1) · Dennis C. Ang, MD (1) · Doh Kwan Kim, MD PhD (1)
PMID 26112278, PMID 19108787, PMID 20156949, PMID 20496365, PMID 21459941, PMID 22429066, PMID 23446065, PMID 23953493, PMID 24030685, PMID 24188161, PMID 24392250, PMID 24800123, PMID 25664215, PMID 25873248, PMID 25998206, PMID 26335989, PMID 26414990, PMID 26628607, PMID 33982890, PMID 36269595
2014 (1), K23AR057578 (1), R21AR056046 (1)